Keywords: celegene, 2nd-qtr, income, soars, drugmaker, second-quarter, net
Celegene's 2nd-qtr 2007 income soars 187.2%
Article | 06 August 2007
US drugmaker Celegene's second-quarter 2007 net income totaled $54.9 million, or $0.13 per share, versus $9.6 million, or $0.03 per share, including an after-tax share-based ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Elan puts up formal "for sale" notice
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
